Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4648890
Max Phase: Preclinical
Molecular Formula: C41H39ClF2N12O7
Molecular Weight: 885.29
Molecule Type: Unknown
Associated Items:
ID: ALA4648890
Max Phase: Preclinical
Molecular Formula: C41H39ClF2N12O7
Molecular Weight: 885.29
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C1CCC(N2C(=O)c3cccc(NCCn4cc(CCCC(=O)N[C@@H]5CCN(c6ncc(C(=O)Nc7ccc(OC(F)(F)Cl)cc7)cc6-c6cc[nH]n6)C5)nn4)c3C2=O)C(=O)N1
Standard InChI: InChI=1S/C41H39ClF2N12O7/c42-41(43,44)63-27-9-7-24(8-10-27)49-37(59)23-19-29(30-13-15-47-52-30)36(46-20-23)54-17-14-25(21-54)48-33(57)6-1-3-26-22-55(53-51-26)18-16-45-31-5-2-4-28-35(31)40(62)56(39(28)61)32-11-12-34(58)50-38(32)60/h2,4-5,7-10,13,15,19-20,22,25,32,45H,1,3,6,11-12,14,16-18,21H2,(H,47,52)(H,48,57)(H,49,59)(H,50,58,60)/t25-,32?/m1/s1
Standard InChI Key: KHHQVHBDTLVQLY-LYYPKXFYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 885.29 | Molecular Weight (Monoisotopic): 884.2721 | AlogP: 3.71 | #Rotatable Bonds: 16 |
Polar Surface Area: 238.53 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 19 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.59 | CX Basic pKa: 4.98 | CX LogP: 4.19 | CX LogD: 4.19 |
Aromatic Rings: 5 | Heavy Atoms: 63 | QED Weighted: 0.07 | Np Likeness Score: -1.61 |
1. Yang Y, Gao H, Sun X, Sun Y, Qiu Y, Weng Q, Rao Y.. (2020) Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug-Resistant Mutants and Adverse Effects., 63 (15): [PMID:32657579] [10.1021/acs.jmedchem.0c00967] |
Source(1):